MENU
CMMB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Chemomab Therapeutics (CMMB) Ownership - Who owns Chemomab Therapeutics?
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Kiryat Atidim
Phone
+972 773310156
Employees
20
Web
https://www.chemomab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23M
P/E Ratio
N/A
Total Cash
10.56M
Projected Growth
N/A
Total Debt
292K
Revenue
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CMMB
Capitalization
23M
P/E Ratio
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
10.6M
Total Cash/Share
0.55
Total Debt
292K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
10.4M
P/B Ratio
2.21
Cash Flow
N/A
Earnings
-0.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
5.33
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-14.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-86.93
Shares Held By Institutions
4.98M
Shares Outstanding - Current
19.2M
Total Liabilities
2.43M
Total Volume MTD
N/A
Value
1
Gain YTD
-33.702
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of biopharmaceutical services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Kiryat Atidim
Phone
+972 773310156
Employees
20
Web
https://www.chemomab.com